These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9865726)

  • 41. [Potentiation of radiosensitivity by staurosporine associated with abrogation of G2 phase arrest].
    Sun XC; Wang JJ; Zhen YS; Shao RG
    Yao Xue Xue Bao; 2002 Jun; 37(6):419-23. PubMed ID: 12579796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide.
    Jiang X; Zhao B; Britton R; Lim LY; Leong D; Sanghera JS; Zhou BB; Piers E; Andersen RJ; Roberge M
    Mol Cancer Ther; 2004 Oct; 3(10):1221-7. PubMed ID: 15486189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New okadaic acid analogues from the marine sponge Merriamum oxeato and their effect on mitosis.
    Britton R; Roberge M; Brown C; van Soest R; Andersen RJ
    J Nat Prod; 2003 Jun; 66(6):838-43. PubMed ID: 12828471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-throughput assay for G2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide.
    Roberge M; Berlinck RG; Xu L; Anderson HJ; Lim LY; Curman D; Stringer CM; Friend SH; Davies P; Vincent I; Haggarty SJ; Kelly MT; Britton R; Piers E; Andersen RJ
    Cancer Res; 1998 Dec; 58(24):5701-6. PubMed ID: 9865726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy.
    Anderson HJ; Andersen RJ; Roberge M
    Prog Cell Cycle Res; 2003; 5():423-30. PubMed ID: 14593736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implication of the G2 checkpoint in the maintenance of genome integrity.
    Piette J; Muñoz P
    Pathol Biol (Paris); 2000 Apr; 48(3):174-81. PubMed ID: 10858951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. P53 pathways involving G2 checkpoint regulators and the role of their subcellular localisation.
    Winters ZE
    J R Coll Surg Edinb; 2002 Aug; 47(4):591-8. PubMed ID: 12363184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition.
    Deslandes S; Chassaing S; Delfourne E
    Mar Drugs; 2009 Dec; 7(4):754-86. PubMed ID: 20098609
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.